KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $4.1 billion.

  • Charles River Laboratories International's Total Liabilities fell 270.9% to $4.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 billion, marking a year-over-year decrease of 270.9%. This contributed to the annual value of $4.0 billion for FY2024, which is 1136.98% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Total Liabilities of $4.1 billion as of Q3 2025, which was down 270.9% from $4.2 billion recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Total Liabilities ranged from a high of $4.8 billion in Q2 2022 and a low of $3.6 billion during Q1 2021
  • In the last 5 years, Charles River Laboratories International's Total Liabilities had a median value of $4.4 billion in 2022 and averaged $4.4 billion.
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 3972.14% in 2021, then tumbled by 1136.98% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Total Liabilities (Quarter) stood at $4.4 billion in 2021, then increased by 3.32% to $4.6 billion in 2022, then fell by 0.94% to $4.5 billion in 2023, then decreased by 11.37% to $4.0 billion in 2024, then grew by 1.06% to $4.1 billion in 2025.
  • Its Total Liabilities stands at $4.1 billion for Q3 2025, versus $4.2 billion for Q2 2025 and $4.3 billion for Q1 2025.